Indivior Pharmaceuticals INDV
NASDAQ INDV
$34.79 +0.02 (+0.06%)
At close: Oct 21, 2026 · 4:00 PM EDT

Indivior Pharmaceuticals (INDV) Notes Payables (2021 - 2023)

Updated

Indivior Pharmaceuticals (INDV) reported Notes Payables of $3 million for Q4 2023, unchanged from $3 million a year earlier.

Analysis

Indivior Pharmaceuticals (INDV) Notes Payables (2021 - 2023) Analysis & Trends

  • By year, Notes Payables came in at $3 million in FY2022 (unchanged) and $3 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Indivior Pharmaceuticals 4.13 Bn 3.10 Bn 294.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 3.00 Mn
Dec 31, 2022 3.00 Mn
Dec 31, 2021 3.00 Mn
API Access

Indivior Pharmaceuticals Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=INDV&period=max&api_key=YOUR_API_KEY